Pavel Raifeld
Directeur Général chez INNOVIVA, INC.
Fortune : 174 873 $ au 30/04/2024
Provenance du réseau au premier degré de Pavel Raifeld
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 13 | |
Subsidiary | Biotechnology | 12 | |
Public Company | Pharmaceuticals: Major | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Pavel Raifeld via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer Investor Relations Contact Founder Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ODONATE, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Director of Finance/CFO | |
ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
HERON THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member President | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
State University of New York at Albany | College/University | Undergraduate Degree Doctorate Degree | |
Texas A&M University | College/University | Undergraduate Degree Undergraduate Degree | |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Wellesley College | College/University | Undergraduate Degree Undergraduate Degree | |
FUSN PHAR | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Chief Executive Officer | |
University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
SARISSA CAPITAL ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Founder Director/Board Member | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
JMP Securities LLC
JMP Securities LLC Investment Banks/BrokersFinance Citizens JMP Securities LLC (Citizens JMP) is a full-service investment bank and broker/dealer headquartered in San Francisco, California. The firm was founded by Joseph Jolson in 2002 and was formerly JMP Securities LLC. The firm is a subsidiary of JMP Holding LLC, ultimately held by Citizens Financial Group, Inc. (NYSE: CFG). Citizens JMP provides equity research, institutional brokerage, and investment banking services to public and private growth companies and their investors. They are a research-driven, growth-oriented firm that provides services to small- and mid-sized companies and the institutions that invest in them. The firm specializes in four high-growth sectors of the economy: technology, healthcare, financial services, and real estate. | Investment Banks/Brokers | Analyst-Equity | |
Astellas Research Institute of America LLC | Corporate Officer/Principal | ||
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
Weizmann Institute of Science | College/University | Graduate Degree | |
Tufts University | College/University | Undergraduate Degree | |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Investment Banks/Brokers | Analyst-Equity | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Corporate Officer/Principal | |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
Sofinnova Ventures | Corporate Officer/Principal | ||
The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Corporate Officer/Principal | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Cincinnati (Ohio) | College/University | Undergraduate Degree | |
BAXALTA INC | Biotechnology | Corporate Officer/Principal | |
IPSEN | Pharmaceuticals: Major | Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
Ipsen Manufacturing Ireland Ltd.
Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chairman | |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
UNIQURE N.V. | Biotechnology | Chairman | |
DESIGN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
MGM Networks, Inc.
MGM Networks, Inc. Movies/EntertainmentConsumer Services Part of Liberty Global Ltd., MGM Networks, Inc. is a company that produces motion picture production and video production. The company is based in Los Angeles, CA. MGM Networks was acquired by Liberty Global Content Investments Ltd. from Metro-Goldwyn-Mayer, Inc. on August 01, 2012 for $72.20 million. | Movies/Entertainment | President | |
Spelling Entertainment Group LLC
Spelling Entertainment Group LLC Movies/EntertainmentConsumer Services Part of Paramount Global, Spelling Entertainment Group LLC is a company that produces and distributes television series, mini-series, and movies for television. The company is based in Los Angeles, CA. Spelling Entertainment Group was acquired by Viacom, Inc. /Old/ on June 21, 1999 for $176.47 million. | Movies/Entertainment | President | |
Itc Entertainment Group Ltd
Itc Entertainment Group Ltd Movies/EntertainmentConsumer Services Part of Koninklijke Philips NV, Itc Entertainment Group Ltd distributes motion pictures and video tapes. The company is based in Studio City, CA. Itc Entertainment Group was acquired by Philips Electronics UK Ltd. on January 01, 1995 for $155.86 million. | Movies/Entertainment | Chief Executive Officer |
Statistiques
Internationale
Etats-Unis | 42 |
Canada | 3 |
Irlande | 3 |
France | 3 |
Suède | 2 |
Sectorielle
Health Technology | 26 |
Consumer Services | 13 |
Finance | 10 |
Commercial Services | 3 |
Opérationnelle
Director/Board Member | 162 |
Corporate Officer/Principal | 82 |
Independent Dir/Board Member | 68 |
Undergraduate Degree | 32 |
Director of Finance/CFO | 30 |
Relations les plus connectées
Insiders | |
---|---|
George Bickerstaff | 37 |
Heather Elizabeth Preston | 34 |
Jules Haimovitz | 27 |
Sapna R. Srivastava | 21 |
Sarah Schlesinger | 19 |
David Meek | 19 |
Kevin Tang | 18 |
Craig Johnson | 17 |
Heather Behanna | 15 |
David Ramsay | 13 |
Larry G. Edwards | 12 |
David Hastings | 12 |
Odysseas Kostas | 11 |
Laura Douglass | 10 |
David Altarac | 9 |
- Bourse
- Insiders
- Pavel Raifeld
- Connexions Sociétés